GREAT POINT PARTNERS LLC 13D and 13G filings for KalVista Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:59 pm Sale |
2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
GREAT POINT PARTNERS LLC | 1,055,801 3.100% |
-224,199 (-17.52%) |
Filing |
| 2022-05-18 4:03 pm Purchase |
2022-05-09 | 13G | KalVista Pharmaceuticals, Inc. KALV |
GREAT POINT PARTNERS LLC | 1,280,000 5.220% |
1,280,000 (New Position) |
Filing |